Acute hepatitis with portal and mesenteric vein thrombosis revealing SARS-CoV-2 infection: Case report and literature review

Harouachi, Abdelhakim; Bouhout, Tariq; Kacem, H. Hadj; Serji, Badr; Berkhli, Hayat; Madani, Hamid; Harroudi, Tijani El

doi:10.1016/j.amsu.2022.103706

Cited by 1 publication

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ursodeoxycholic acid (UDCA) has been reported to give promising results; however, for a proportion of these patients, transplantation is required[ 72 ]. Rare but devastating clinical presentations include liver abscess with necrosis[ 73 ] and vascular thrombotic events in abdominal vessels such as portal and mesenteric vein thrombosis[ 74 ].…”

Section: Critically Ill Patients With Acute Liver Disease and Covid-19mentioning

confidence: 99%

Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19

Valsamaki¹,

Xanthoudaki²,

Oikonomou³

et al. 2023

World J Clin Cases

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, broke out in December 2019 in Wuhan city of China and spread rapidly worldwide. Therefore, by March 2020, the World Health Organization declared the disease a global pandemic. Apart from the respiratory system, various other organs of the human body are also seriously affected by the virus. Liver injury in patients with a severe form of COVID-19 is estimated to be 14.8%-53.0%. Elevated levels of total bilirubin, aspartate aminotransferase and alanine aminotransferase and low levels of serum albumin and prealbumin are the main laboratory findings. Patients with pre-existing chronic liver disease and cirrhosis are much more prone to develop severe liver injury. This literature review presented the recent scientific findings regarding the pathophysiological mechanisms responsible for liver injury in critically ill patients with COVID-19, the various interactions between drugs used to treat the disease and the function of the liver and the specific tests providing the possibility of early diagnosis of severe liver injury in these patients. Moreover, it highlighted the burden that COVID-19 put on health systems worldwide and its effect on transplant programs and the care provided to critically ill patients in general and particularly to those with chronic liver disease.

show abstract

Section: Critically Ill Patients With Acute Liver Disease and Covid-19mentioning

confidence: 99%

Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19

Valsamaki¹,

Xanthoudaki²,

Oikonomou³

et al. 2023

World J Clin Cases

View full text Add to dashboard Cite

show abstract

Acute hepatitis with portal and mesenteric vein thrombosis revealing SARS-CoV-2 infection: Case report and literature review

Cited by 1 publication

References 25 publications

Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19

Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19

Contact Info

Product

Resources

About